A61L 2300/602
Type of release
Official title: Type of release, e.g. controlled, sustained, slow
A61L2300/602 (Type of release) appears on 1,431 US grants and 2,133 published applications in this corpus.
Search patents in A61L- Granted patents
- 1,431
- Published applications
- 2,133
- Assignees
- 873
- Inventors
- 3,502
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 11 | 0 |
| 1994 | 22 | 0 |
| 1995 | 21 | 0 |
| 1996 | 19 | 0 |
| 1997 | 32 | 0 |
| 1998 | 40 | 0 |
| 1999 | 32 | 0 |
| 2000 | 24 | 0 |
| 2001 | 29 | 8 |
| 2002 | 34 | 74 |
| 2003 | 28 | 102 |
| 2004 | 35 | 104 |
| 2005 | 26 | 97 |
| 2006 | 28 | 121 |
| 2007 | 26 | 136 |
| 2008 | 26 | 111 |
| 2009 | 22 | 114 |
| 2010 | 50 | 125 |
| 2011 | 60 | 105 |
| 2012 | 65 | 88 |
| 2013 | 70 | 77 |
| 2014 | 96 | 97 |
| 2015 | 86 | 113 |
| 2016 | 89 | 124 |
| 2017 | 72 | 71 |
| 2018 | 69 | 83 |
| 2019 | 51 | 85 |
| 2020 | 53 | 48 |
| 2021 | 53 | 46 |
| 2022 | 26 | 49 |
| 2023 | 26 | 44 |
| 2024 | 32 | 56 |
| 2025 | 29 | 39 |
| 2026 | 13 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Color-changing antibacterial nanofiber29 Sep 2026US 12,746,214 B2University of Manitoba
- Method for manufacturing hemostatic medical material15 Sep 2026US 12,734,267 B2
- Active agent-eluting hemostatic agents for prevention of surgical site infection1 Sep 2026US 12,721,928 B1Florida Southern College
- Medical instrument23 Jun 2026US 12,661,435 B2The University of Tokyo
- Porous nanocomposite medical implant device9 Jun 2026US 12,648,904 B2Lynthera Corporation
- Segmented calcium phosphate bone scaffolds with sacrificial zones for mechano-transductive bone regeneration and methods of making and using the same1 Oct 2026US 2026/0294629 A1Board of Regents, The University of Texas System
- Target for combatting the foreign body response to implantable biomaterials1 Oct 2026US 2026/0295119 A1The Regents of the University of Colorado, a body corporate
- Hyaluronic acid-based gels including lidocaine24 Sep 2026US 2026/0284270 A1Allergan Industrie, SAS
- Sustained Release Liposomal Pharmaceutical Embolizing Agents for Treating Chronic Subdural Hematoma, Intractable Migraines, Headaches, and Other Pain Conditions17 Sep 2026US 2026/0272468 A1MG Stroke Analytics Inc.
- Bacteriophage cocktail-containing hydrogel compositions and methods of production and use thereof17 Sep 2026US 2026/0273143 A1
Most cited
By later US patents
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Sutures and surgical staples for anastamoses, wound closures, and surgical closures1,385US 8,016,881 B2ICON Interventional Systems, Inc. · 2011
- Coated implantable medical device1,180US 6,096,070 ACook Incorporated · 2000